| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2873759 | The Annals of Thoracic Surgery | 2015 | 7 Pages |
Abstract
Results for re-LTx have improved over time, especially when BOS is the primary indication. The cumulative incidence among patients who underwent re-LTx because of BOS and developed repeat BOS after re-LTX showed equal risk between 1992 to 1999 and 2000 to 2013 in the aspect of developing repeat BOS, but in the later era the patients had a significantly higher chance of surviving.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sandra MD, PhD, Göran MD, PhD, Martin MD, Gerdt C. MD, Ãystein MD, Pekka MD, Ingrid MD, Arnt MD, Per MD, PhD, Nordic Thoracic Transplantation Study Group (NTTSG) Nordic Thoracic Transplantation Study Group (NTTSG),